Literature DB >> 28266909

Exposure to 1,2-Propanediol Impacts Early Development of Zebrafish (Danio rerio) and Induces Hyperactivity.

Andrey Massarsky1, Ayham Abdel1, Lilah Glazer2, Edward D Levin2, Richard T Di Giulio1.   

Abstract

The use of electronic cigarettes (e-cigarettes) is increasing as an alternative to tobacco burning cigarettes; however, their safety remains to be fully determined. The long-term effects of e-cigarettes are unknown, including the effects of maternal e-cigarette use on pre- and postnatal development. Additional research on the safety of e-cigarettes is needed. Especially useful would be information from high- and moderate-throughput economic model systems. This study investigates the effects of 1,2-propanediol, which was identified as the main component of e-cigarette liquid, on early development of zebrafish (an in vivo high-throughput model system that was recently proposed for the study of tobacco cigarette and e-cigarette toxicity). Zebrafish embryos were exposed to 1.25% or 2.5% 1,2-propanediol from 6 to 72 h post-fertilization (hpf). We show that exposure to 1,2-propanediol did not significantly affect mortality. Hatching success was significantly lower in 2.5% 1,2-propanediol-exposed embryos at 48 hpf, but at 72 hpf no significant differences were noted. Moreover, exposure to 1,2-propanediol reduced growth and increased the incidence of string heart, pericardial edema, and yolk sac edema. Most importantly, developmental exposure to 1.25% 1,2-propanediol caused hyperactive swimming behavior in larvae. This study demonstrates that 1,2-propanediol has adverse impacts on early development in zebrafish.

Entities:  

Keywords:  1,2-propanediol (propylene glycol); behavior; early development; electronic cigarettes; zebrafish

Mesh:

Substances:

Year:  2017        PMID: 28266909     DOI: 10.1089/zeb.2016.1400

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  7 in total

1.  Neurobehavioral effects of 1,2-propanediol in zebrafish (Danio rerio).

Authors:  Andrey Massarsky; Ayham Abdel; Lilah Glazer; Edward D Levin; Richard T Di Giulio
Journal:  Neurotoxicology       Date:  2018-02-09       Impact factor: 4.294

2.  E-liquids and vanillin flavoring disrupts retinoic acid signaling and causes craniofacial defects in Xenopus embryos.

Authors:  Amanda J G Dickinson; Stephen D Turner; Stacey Wahl; Allyson E Kennedy; Brent H Wyatt; Deborah A Howton
Journal:  Dev Biol       Date:  2021-09-17       Impact factor: 3.582

3.  Assessing the hazard of E-Cigarette flavor mixtures using zebrafish.

Authors:  Laura L Holden; Lisa Truong; Michael T Simonich; Robert L Tanguay
Journal:  Food Chem Toxicol       Date:  2019-11-08       Impact factor: 6.023

Review 4.  The chemistry and toxicology of vaping.

Authors:  Emily Bonner; Yvonne Chang; Emerson Christie; Victoria Colvin; Brittany Cunningham; Daniel Elson; Christine Ghetu; Juliana Huizenga; Sara J Hutton; Siva K Kolluri; Stephanie Maggio; Ian Moran; Bethany Parker; Yvonne Rericha; Brianna N Rivera; Samantha Samon; Trever Schwichtenberg; Prarthana Shankar; Michael T Simonich; Lindsay B Wilson; Robyn L Tanguay
Journal:  Pharmacol Ther       Date:  2021-03-19       Impact factor: 13.400

5.  E-cigarette aerosol exposure can cause craniofacial defects in Xenopus laevis embryos and mammalian neural crest cells.

Authors:  Allyson E Kennedy; Suraj Kandalam; Rene Olivares-Navarrete; Amanda J G Dickinson
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 6.  Zebrafish Models of Craniofacial Malformations: Interactions of Environmental Factors.

Authors:  S T Raterman; J R Metz; Frank A D T G Wagener; Johannes W Von den Hoff
Journal:  Front Cell Dev Biol       Date:  2020-11-16

7.  Survivorship-Reducing Effect of Propylene Glycol on Vector Mosquito Populations and Its Potential Use in Attractive Toxic Sugar Baits.

Authors:  Heidi Pullmann Lindsley; Henry B Lyons; Melissa Leon-Noreña; Ronald Jason Pitts
Journal:  Insects       Date:  2022-06-29       Impact factor: 3.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.